Axis Bio offers a range of syngeneic models to test your novel immunotherapeutic agents; many of these have been validated against checkpoint inhibitors. These models can be run as subcutaneous or orthotopic models and we have in-house FACS and IHC capabilities to back-up any efficacy data.